James Harris III: CEO: has extensive experience within biotech, pharmaceuticals and medical devices with small start-ups, mid-sized and large firms. Mr. Harris is the founder of Healthcare Economics LLC, co-founder of AS Biotech AG and participates on the board of directors as well as advisory boards for various firms. Prior to this he served as General Manager and Vice President at Dragon Pharmaceuticals, Inc. where he was instrumental in the launch and successful market penetration of rh-Erythropoietin (“EPO") in non patented markets and is very well experienced in product licensing, business development, market access and reimbursement. Mr. Harris’s publications include “Biosimilars landscape and FDA regulatory expectations”, “Generic Drugs: World Market Outlook 2011-2021”, “Patient Empowerment and Compliance: The Role of Direct to Consumer (DTC) Advertising”, “Marketing and Globalizing Biosimilars”, “How to Establish Comparability for a faster route to Market, and “GCSF and Bioequivalence: The Emergence of Healthcare Economics”. Mr. Harris is Lead Faculty Area Chair – Financial Planning and Risk Control at the University of Phoenix West Florida Campus, has an MBA in Finance from Long Island University and participates extensively as a featured speaker at medical meetings globally.